Ptc Therapeutics (PTCT) FCF Margin (2012 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly FCF Margin of 22.1% in Q1 2026, up 0.68% quarter-over-quarter from 22.25% in Q4 2025, and down 9594.0% on a YoY basis from 0.23% in Q1 2025.
Ptc Therapeutics (PTCT) FCF Margin (2012 - 2026) Analysis & Trends
Ptc Therapeutics' FCF Margin history runs 15 years deep, the most recent figure standing at 22.1% for Q1 2026.
- In Q1 2026, FCF Margin fell 9594.0% year-over-year to 22.1%; the TTM figure through Mar 2026 stood at 27.36% (down 7146.0% YoY), while the FY2025 annual figure was 40.58%, up 5394.0% from the prior year.
- FCF Margin was 22.1% for Q1 2026 at Ptc Therapeutics, up from 22.25% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 73.84% in Q1 2025 to a low of 104.28% in Q4 2022.
- Historically, FCF Margin has averaged 23.01% across 5 years, with a median of 22.18% in 2026.
- The sharpest annual moves came in 2023 and 2026: FCF Margin surged 6981 bps in 2023, then tumbled 9594 bps in 2026.
- A 5-year view of FCF Margin shows it stood at 104.28% in 2022, then jumped by 67 bps to 34.47% in 2023, then soared by 63 bps to 12.82% in 2024, then sank by 74 bps to 22.25% in 2025, then gained by 1 bps to 22.1% in 2026.
- The last three FCF Margin figures came in at 22.1% (Q1 2026), 22.25% (Q4 2025), and 33.05% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn | -22.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.10% |
| Dec 31, 2025 | -22.25% |
| Sep 30, 2025 | -33.05% |
| Jun 30, 2025 | -33.35% |
| Mar 31, 2025 | 73.84% |
| Dec 31, 2024 | -12.82% |
| Sep 30, 2024 | -39.39% |
| Mar 31, 2024 | 29.11% |
| Dec 31, 2023 | -34.47% |
| Sep 30, 2023 | -19.00% |
| Jun 30, 2023 | -6.61% |
| Mar 31, 2023 | -13.39% |
| Dec 31, 2022 | -104.28% |
| Sep 30, 2022 | -20.00% |
| Jun 30, 2022 | -38.63% |
| Mar 31, 2022 | -71.75% |
| Dec 31, 2021 | -46.94% |
| Sep 30, 2021 | -41.11% |
| Jun 30, 2021 | -33.53% |
| Mar 31, 2021 | -89.73% |